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Introduction
Estrogen is vital for normal postpubertal mammary develop-
ment, as well as for growth of the majority of breast cancers 
(Sternlicht, 2006; Yager and Davidson, 2006). The relationship 
between mammary stem cells and hormone receptor–expressing 
cells is therefore a fundamental issue in breast biology. It is 
known that in both the developing and the adult mammary gland 
only a subset of cells express the estrogen receptor (ER). How-
ever, there are confl icting views as to the role of these cells. It 
has been proposed that ER-positive cells form a stem cell com-
partment that is directly stimulated by circulating hormones 
(Cheng et al., 2004; Clarke et al., 2005). Alternatively, ER-positive 
cells may stimulate proliferation of a separate stem cell compart-
ment in a paracrine manner (Mallepell et al., 2006).
Evidence that ER-positive cells form a stem cell compart-
ment has come from studies of cell cycling times and prolifera-
tion in both human and rodent tissues. ER- and progesterone 
receptor–positive cells in the mouse mammary epithelium have 
been identifi ed as cells that retain BrdU (label-retaining cells) 
in pulse–chase experiments (Zeps et al., 1998, 1999; Welm 
et al., 2002; Smith, 2005), suggesting that they form a slowly 
cycling cell compartment. Slow in vivo cycling time is thought 
to be a property of stem cells (Welm et al., 2002; Clarke et al., 
2005). Consistent with the slow cycling times is the observation 
that, in the normal human adult tissue, ER-positive cells do not 
express markers of proliferation (Clarke et al., 1997). It has 
been proposed that ER down-regulation occurs in these cells 
before the proliferative response, as stimulation with estrogen 
led to a decrease in ER expression within 4 h in mice (Cheng 
et al., 2004).
The paracrine stimulation theory is supported by observa-
tions that ER-null mammary cells can reconstitute the mammary 
epithelial network in cleared fat pad transplantation experiments 
only if cotransplanted with mammary cells from ER wild-type 
mice (Mallepell et al., 2006). Resolution of this issue requires 
prospective isolation and functional analysis of the ER-expressing 
cellular compartment. We have used such an approach to directly 
demonstrate that the mammary epithelium contains separate 
hormone-sensing and stem/progenitor compartments.
Results and discussion
Sca-1 and prominin-1 expression defi ne 
a distinct subpopulation of mouse 
mammary luminal epithelial cells
The mouse mammary epithelium consists of two cell com-
partments, an outer layer of basal epithelial cells, the majority 
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of which are functionally specialized myoepithelial cells, and 
an inner layer of luminal epithelial cells. These cells can be 
distinguished by expression of cell type–specifi c cytoskeletal 
markers (Fig. S1 A, available at http://www.jcb.org/cgi/
content/full/jcb.200604065/DC1; Smalley et al., 1998). We 
have previously described CD24 as a marker that allows the 
separation and isolation of the luminal (CD24High) and basal 
(CD24Low) compartments of the mouse mammary epithelium 
(Sleeman et al., 2006). To prospectively isolate further sub-
populations of the mammary epithelium, we costained mouse 
mammary cell preparations with CD24-FITC and two cell-
surface markers of mouse hematopoietic stem cells, Sca- and 
prominin-1 (Fig. 1). Costaining with CD24 and Sca-1 defi ned 
a CD24Negative/Sca-1+ nonepithelial population and a CD24High/
Sca-1+ luminal epithelial population (Fig. 1 A). Costaining with 
CD24 and prominin-1 defi ned only a CD24High/prominin-1+ 
population. No cells from the nonepithelial compartment 
stained with this marker. Simultaneous staining with CD24, 
Sca-1, and prominin-1 revealed an almost complete over-
lap between CD24High/Sca-1+ and CD24High/prominin-1+ cell 
populations (Fig. 1 B).
To confi rm the luminal epithelial nature of the CD24High/
prominin-1− and CD24High/prominin-1+ populations, cells 
from both these compartments and the CD24Low population 
were sorted onto slides and stained for expression of the basal 
epithelial cell marker cytokeratin 14 (CK14) and the luminal 
epithelial cell marker, CK8/18 (CK18). The results (Fig. 1 C) 
confi rmed that the majority of CD24Low cells were CK14+ 
basal cells and that the CD24High/prominin-1− and CD24High/
prominin-1+ populations were CK18+ luminal cells. Unexpectedly, 
the CD24High/prominin-1+ cells had more intense CK18 expres-
sion than the CD24High/prominin-1− cells, suggesting that these 
were functionally distinct populations. Staining of the epithelial 
populations defi ned by CD24 and Sca-1 staining gave essen-
tially identical results (unpublished data).
To confi rm that the CD24Low population consisted pre-
dominantly of basal myoepithelial cells, CD24Low cells were 
sorted onto slides and double stained with antibodies against 
CK14 and α-isoform smooth muscle actin (SMA). As expected, 
the majority (>90%) were indeed CK14+/SMA+ myoepithelial 
cells (Fig. S1 B). Keratin-negative cells were also present, and 
a small number of CK14+/SMA-negative cells were observed.
Figure 1. CD24, Sca-1, and prominin-1 ex-
pression defi ne a distinct mammary epithelial 
cell compartment. (A) Flow cytometric stain-
ing patterns of freshly isolated mouse mam-
mary cells stained for CD24 expression (left) 
and CD24 and Sca-1 expression (right). Only 
live, single CD45−cells were included in the 
analysis. (B) Flow cytometric staining patterns 
of freshly isolated mouse mammary cells triple 
stained for CD24, prominin-1, and Sca-1 
expression. The CD24 and prominin-1 staining 
pattern is shown on the left, and the Sca-1 and 
prominin-1 staining pattern of the CD24High 
fraction is shown only on the right. (C) Analysis 
of cytoskeletal antigen expression in cells sep-
arated by CD24 and prominin-1 expression. 
Results of three independent cell isolations in 
which freshly isolated cells were sorted onto 
slides and single stained for CK14 or CK18. 
Numbers represent the percentage of positive 
cells ± the SD for three experiments. The total 
numbers of cells observed are given below the 
percentages. Intensity of CK18 staining is indi-
cated by CK18+ (weak) and CK18++ (strong).
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CD24High/prominin-1+ cells 
are a specialized hormone-sensing 
luminal epithelial compartment
To characterize the potential functional roles of the compart-
ments defi ned by CD24 and prominin-1 staining, including the 
expression of hormone receptors, expression of several genes 
(Table S1, available at http://www.jcb.org/cgi/content/full/
jcb.200604065/DC1) relative to total mammary epithelial cell 
expression was analyzed by quantitative real time PCR (qPCR). 
In the CD24Low population, as expected, there was increased 
expression of the myoepithelial/basal cytoskeletal markers 
Krt1-14 (CK14), Krt2-5 (CK5), and Vim. Myl6 and Tpm2B, 
which are two genes involved in actin–myosin activity, were 
also up-regulated in this population, refl ecting the contractile 
function of myoepithelial cells. In both CD24High populations, 
expression of luminal cytoskeletal markers was elevated.
CD24High/prominin-1− cells had signifi cantly elevated levels 
of Krt1-18 (CK18), whereas in CD24High/prominin-1+ cells, 
expression of both Krt1-18 and Krt1-19 (CK19) was signifi cantly 
increased (Fig. 2 A). 
Analysis of expression of fi ve genes involved in sensing 
systemic hormones, Esr (ERα), Pr (progesterone receptor), 
Prlr (prolactin receptor), Cited1, and S100A6, demonstrated 
that all of these genes were signifi cantly up-regulated in CD24High/
prominin-1+ cells (Fig. 2 B). Four out of the fi ve genes were also 
signifi cantly down-regulated in the CD24Low and the CD24High/
prominin-1− populations. Cited1 is involved in transcriptional 
coactivation together with ER (Yahata et al., 2001), and S100A6 
is a calcium-binding protein that is likely to have several cellu-
lar functions, including binding the prolactin receptor (Murphy 
et al., 1988). The pattern of expression of these fi ve genes 
strongly suggests that the CD24High/prominin-1+ cell population 
forms a specifi c hormone-sensing compartment.
As the ultimate purpose of the mammary epithelium 
is milk production, the expression of four genes for milk 
 prot eins (Csnβ, Ltf, Mfge8, and Wap) was examined (Fig. 2 C). 
Figure 2. qPCR analysis identifi es a hormone receptor–expressing cell population. (A) Cytoskeletal genes. 1A P value could not be determined for 
CD24High/prominin-1+ with CK14, as all three replicates gave a value of 0. 2A P value could not be determined for CD24High/prominin-1− or CD24High/
prominin-1+ with CK5, as in both cases two of the three samples gave a value of 0. (B) Hormone response genes. (C) Milk component genes. (D) Miscella-
neous genes. Each data point on each graph is a mean ± the SD of fold-relative expression of the gene in three independently isolated samples of the popu-
lation of interest compared with total mammary epithelial cells. The fold-relative expression for each sample is itself a mean of two independent cDNA 
syntheses performed on that sample. *, P < 0.05; **, P < 0.01; ***, P < 0.001.
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Despite the fact that the cells assayed were harvested from 
virgin animals, both Csnβ and Ltf were signifi cantly more 
highly expressed in the CD24High/prominin-1− population, 
compared with total mammary epithelium. There was also 
elevated expression of Mfge8 and Wap in these populations, but 
this did not achieve signifi cance. These analyses therefore 
confi rmed the basal/myoepithelial and luminal identities of the 
CD24Low and CD24High populations, respectively, and suggested 
that prominin-1 expression is a marker of two different 
functional lu minal epithelial populations, a hormone-sensing 
compartment (prominin-1+), and a compartment containing 
cells involved in milk production (prominin-1−).
As expected, the CD24High/prominin-1+ hormone receptor–
expressing population had very strongly up-regulated levels of 
both Prominin-1 (Prom1) and Sca-1 (Ly6A/Sca-1; Fig. 2 D). 
CD24 expression was signifi cantly increased in this population, 
and it signifi cantly decreased in the CD24Low population. CD44, 
which is a marker of basal cells (Fonseca et al., 2000) and breast 
cancer stem cells (Al-Hajj et al., 2003), was signifi cantly de-
creased in CD24High/prominin-1+ luminal cells. Consistent with 
the pattern of expression of cytoskeletal genes, CD24Low cells 
were found to have increased expression of Sparc, which is 
a secreted matrix-binding protein that was previously described 
as a human breast myoepithelial cell marker and a marker 
of poor prognosis in breast cancers (Jones et al., 2004). The 
CD24High/prominin-1− cell population also showed a modest, 
but signifi cantly higher, level of expression of Abcg2, which is 
the gene for breast cancer–resistance protein 1. Abcg2 is an 
ABC transmembrane protein pump that is the main molecular 
determinant of the side population phenomenon (Smalley and 
Clarke, 2005), and that is also localized to the terminally differ-
entiated milk-producing cells of the alveolar epithelium during 
lactation (Jonker et al., 2005). Analysis of gene expression 
within the epithelial populations defi ned by CD24 and Sca-1 
staining gave essentially identical results (unpublished data).
To confi rm that prominin-1+ cells in the mouse mammary 
epithelium were ERα+, frozen sections of adult mouse mam-
mary gland were costained with antibodies against these 
proteins. The results (Fig. 3 A) showed that prominin-1 is apically 
localized on a subset of mouse mammary luminal epithelial 
cells, and also confi rmed that the majority of luminal epithelial 
cells with nuclear ERα staining were prominin-1+. To provide 
quantifi cation, cells were sorted onto slides, stained for nuclear 
ERα, and counted. The data (Fig. 3 B) confi rmed that the 
majority (>80%) of CD24High/prominin-1+ cells were ERα+.
CD24High/prominin-1− cells contain 
the highest proportion of in vitro 
mammary colony-forming cells
To investigate the in vitro progenitor abilities of the CD24Low, 
CD24High/prominin-1−, and CD24High/prominin-1+ populations, 
colony forming assays were performed using freshly isolated 
single cells sorted into individual wells of 96-well plates to de-
termine the relative proportions of mammary colony-forming 
cells (CFCs) within the populations. The results (Fig. 4 A) dem-
onstrated that the CD24High/prominin-1− population contained 
the highest proportion of CFCs, with >40% of cells capable of 
forming colonies in vitro. The CD24High/prominin-1+ popula-
tion contained signifi cantly fewer CFCs (15%). The CD24Low 
population showed very low levels of CFC activity. These 
data support an in vitro progenitor function for the CD24High/
prominin-1− cells.
To derive qualitative information on the colonies formed 
in the CFC assays, freshly isolated single cells sorted from the 
Figure 3. Prominin-1+ cells are ER𝛂+. (A) Frozen section of adult mouse 
mammary gland stained with anti–prominin-1, anti-ERα, and a nuclear 
counterstain (TO-PRO-3). The majority of cells with nuclear ERα staining 
(red; arrows) also show apical prominin-1 staining (green; arrowheads). 
Heavy background staining in the stroma is caused by the Alexa Fluor 555 
antibody used to detect the ERα. (B) To quantify prominin-1/ERα double 
staining, CD24Low, CD24High/prominin-1−, and CD24High/prominin-1+ 
cells were sorted onto slides and stained for nuclear ERα expression. The 
histogram indicates the percentage of ERα+ cells in each population from 
analysis of three independent sorts and the total numbers of cells counted (n). 
Examples of cells from the three populations are shown below the corre-
sponding populations. Nuclear ERα staining (red) can only be seen in 
the CD24High/prominin-1+ population. Signifi cant differences between 
the populations were determined using a t test of log10-transformed data. 
NS, not signifi cant. Bars, 30 μm.
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different populations were cultured on coverslips for 10 d, and 
the colonies generated were stained to assess their CK14 and 
CK18 expression pattern. Colonies derived from CD24Low CFCs 
were small and consisted of only CK14+ cells, which is consistent 
with a basal/myoepithelial origin (Smalley et al., 1998). CFCs 
from both the CD24High/prominin-1− and CD24High/prominin-1+ 
populations formed large colonies that contained cells with 
a heterogeneous staining pattern consisting of both single-
stained CK14+ and CK18+ and double-stained CK14+/CK18+ 
cells, which is consistent with a luminal epithelial cell origin 
(Fig. 4, B–D; Smalley et al., 1998). These data demonstrate that 
the mouse mammary epithelium contains at least two different 
CFCs—basal and luminal.
To determine whether the differences in in vitro colony-
forming ability were refl ected by the proliferative status of the 
three populations, the cell cycle profi le of freshly isolated 
CD24Low, CD24High/prominin-1−, and CD24High/prominin-1+ cells 
was determined. The results (Fig. S1 C) showed that while the 
majority of cells in all three populations were in G0/G1, the per-
centage of cells in S phase in both the CD24High compartments 
was signifi cantly increased compared with the CD24Low cells.
ER-expressing cells of the mouse mammary 
gland have low in vivo stem/progenitor 
cell activity
The aforementioned data establish the existence of three 
distinct cell populations in the mammary epithelium; basal/
myoepithelial cells, defi ned by the CD24Low phenotype, and two 
distinct CD24High luminal epithelial populations, one of which 
is specialized for detecting systemic hormonal signals, and the 
other demonstrating elevated expression of milk protein genes 
and high in vitro colony-forming activity. The key in vivo func-
tional assay for stem/progenitor cell activity in mammary 
epithelium is the cleared fat pad transplant, in which cells are 
transplanted into a mammary fat pad of a 3-wk-old mouse from 
which the endogenous epithelium has been surgically removed 
(DeOme et al., 1959; Smith, 1996). Therefore, to determine the 
in vivo stem cell activity of cells from the different epithelial 
populations, limiting dilution cleared fat pad transplantation of 
prospectively isolated basal epithelial, ER− luminal epithelial, 
and ER+ luminal epithelial cells was performed. Both prominin-1 
and Sca-1 staining were used to separate the ER− and ER+ 
luminal populations in different transplant experiments. In some 
experiments, cells were sorted and then immediately resorted to 
achieve very high purity before transplantation (Fig. S1, D–H). 
Consistent with our previous data (Sleeman et al., 2006), 
CD24Low basal epithelial cells (Fig. 5) were the most highly 
enriched for mammary epithelial stem/progenitor activity. The 
high in vivo growth potential of this population is in contrast to 
their low in vitro cloning effi ciency. Some previous investiga-
tors have demonstrated a similar disparity (Stingl et al., 2006), 
whereas others show good correlation between in vitro and 
in vivo growth (Shackleton et al., 2006). The reasons for these 
differences are not clear, but may be caused by differences 
in sorting strategies, culture conditions, or the ages of mice used 
to isolate cells.
Both luminal ER− and luminal ER+ populations had rates 
of in vivo epithelial outgrowth formation much lower than the 
CD24Low basal cells, with the luminal ER+ populations showing 
the lowest transplantation activity. Double sorting for very high 
purity did not prevent these rare outgrowths from occurring. 
Histological examination showed that outgrowths derived from 
all populations contained SMA-positive myoepithelial cells, 
ER+ luminal epithelial cells, and ER− luminal epithelial cells 
(Fig. 5, C–J). Thus, the in vivo differentiation potential of both 
the transplantable cells present at high frequency in the CD24Low 
Figure 4. CD24High/prominin-1− mammary 
epithelial cells are enriched for in vitro CFCs. 
(A) Bar chart indicating colony-forming effi -
ciencies of single cells sorted into individual 
wells of 96-well plates from CD24Low (fi fteen 
96-well plates from four sorts), CD24High/
prominin-1− (17 96-well plates from 4 sorts), 
and CD24High/prominin-1+ (17 96-well plates 
from 4 sorts) populations. Data are the mean 
percentage cloning effi ciencies ± the SD. 
CFCs, mammary colony forming cells. (B–D) 
Immunophenotyping of 8–10-d-old colonies 
cultured on glass coverslips derived from 
CD24Low (B), CD24High/prominin-1− (C), and 
CD24High/prominin-1+ (D) cells. Stained for 
CK14 (red) and CK18 (green) expression 
and with DAPI (white) to distinguish nuclei. 
Bar, 150 μm.
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population and the rare transplantable cells in the luminal popu-
lations was similar.
Mouse mammary epithelial cell populations highly en-
riched for stem cells (mammary-repopulating units [MRUs]), 
for in vitro colony-forming cells (mammary colony-forming 
cells [MaCFCs]), and for myoepithelial cells (MYOs) have re-
cently been isolated on the basis of expression of CD24 and 
CD49f (Stingl et al., 2006). To relate these populations to the cell 
compartments we have described in this study and in a previous 
work (Sleeman et al., 2006), we identifi ed cells corresponding 
to the MRUs, MaCFCs, and MYOs in mammary epithelial 
cell preparations stained for CD24 and CD49f expression 
(Fig. S2 A, available at http://www.jcb.org/cgi/content/full/
jcb.200604065/DC1). The identity of the MaCFC and MYO 
populations was confi rmed by in vitro colony-forming assays, 
qPCR, and CK staining of cells sorted onto slides (unpublished 
data). Cleared fat pad transplantation activity was used to dem-
onstrate that we had correctly identifi ed the MRUs (Fig. 5 B). 
Mammary cell preparations were simultaneously stained with 
multiple antibodies to identify the MaCFCs, MYOs, and MRUs 
within the CD24Negative, CD24Low, and CD24High populations. 
The results confi rmed that the MRUs fell within the CD24Low 
population, as did the MYOs. The MaCFCs corresponded to the 
CD24High luminal population (Fig. S2, A and B).
In conclusion, we have for the fi rst time prospectively iso-
lated mouse mammary luminal ER+ and ER− cells and directly 
analyzed their cleared fat pad repopulation activity (stem/
progenitor cell activity). Our results indicate that the majority of 
stem/progenitor cell activity in the adult virgin mouse mam-
mary epithelium is located in the basal compartment, con-
fi rming and extending previous observations (Shackleton et al., 
2006; Sleeman et al., 2006; Stingl et al., 2006). In contrast, the 
ER+ luminal compartment contains little in vivo stem/progenitor 
cell activity, indicating that the hormone-sensing and in vivo 
stem/progenitor activities of the mammary epithelium are prop-
erties of distinct, separate cell populations. Gene expression 
Figure 5. Functional assays identify in vivo 
stem/progenitor activity in CD24Low epithe-
lial cells. (A) Results of cleared fat pad trans-
plantation of CD24Low, CD24High/Sca-1−, 
CD24High/Sca-1+, CD24High/prominin-1−, and 
CD24High/prominin-1+ cells. Freshly isolated 
sorted cells were transplanted at dilutions 
ranging from 20,000 to 1,000 cells per fat 
pad. Results from transplants of double-sorted 
populations are indicated by “DS.” (B) Results 
of transplantation of 200 mammary colony 
forming cells (MaCFCs), myoepithelial cells 
(MYOs), or mammary repopulating cells 
(MRUs) isolated by CD24 and CD49f staining. 
For both datasets, the number of successful 
outgrowths and the number of fat pads trans-
planted for each population are indicated. 
Also shown are graphic indications of the ex-
tent to which each transplant fi lled the fat pad. 
ND, not determined. (C–J) Wholemounts and 
sections through representative 100% (C–F) 
and <25% (G–J) transplants. (C, D, G, and H) 
Carmine-stained wholemounts. (E, F, I, and J) 
Sections through transplant outgrowths stained 
for SMA to detect myoepithelial cells (E and I; 
arrows) or for ERα to detect ER+ cells (F and J; 
arrowheads). Bars: (C and G) 6 mm; (D and H) 
2 mm; (E, F, I, and J) 40 μm.
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analysis of the ER− and ER+ luminal epithelial compartments 
revealed evidence of further distinct functional specialization. 
These results will provide a basis for elucidating the nature of 
the interaction between ER− and ER+ luminal epithelial cells 
and basal stem cells in the mammary gland.
Materials and methods
Preparation of single mammary cell suspensions
Mammary epithelial organoids were harvested from fourth mammary fat 
pads of mature, virgin, female 10–12-wk-old FVB mice and processed to 
single cells, as previously described (Sleeman, et al., 2006).
Flow cytometry and cell sorting
Cells were stained as previously described (Sleeman et al., 2006) with 0.5 
μg/ml anti–CD24-FITC (clone M1/69; BD Biosciences), 0.25 μg/ml anti–
CD45-phycoerythrin (PE)-Cy5 (clone 30-F11; BD Biosciences), 0.1 μg/ml 
anti–prominin-1-PE (clone 13A4; Insight Biotechnology), and 0.1 μg/ml 
anti–Sca-1-PE and/or anti–Sca-1-allophycocyanin (clone D7; Cambridge 
Bioscience). 0.01% DAPI or TO-PRO-3 were used to detect dead cells. 
Nonspecifi c IgG controls were used for compensation and to set sort gates. 
Analysis and exclusion of dead cells, CD45+ cells, and nonsingle cells 
was performed as previously described (Sleeman et al., 2006). For double 
sorting of populations, cells were isolated after the fi rst round of sorting, 
pelleted, resuspended in fresh 0.01% TO-PRO-3, and resorted using the 
same gates.
To investigate whether different fl uorochrome conjugates affect 
the staining profi le of CD24, cells at a density of 106 cells/ml were 
stained with 0.5 μg/ml anti–CD24-FITC (clone M1/69), anti–CD24-PE 
(clone M1/69; tested at a range of concentrations from 0.2 μg/ml up to 
10 μg/ml), 0.25 μg/ml anti–CD24-PE-Cy5 (clone M1/69), or 0.5 μg/ml 
unconjugated anti-CD24 (clone M1/69), followed by anti–rat–Alexa Fluor 
633 (A-21094; 20 μg/ml) in a two-step procedure. To confi rm that popu-
lations identifi ed with different fl uorochrome conjugates were identical, 
cells at a density of 106 cells/ml were stained simultaneously with 0.5 μg/ml 
anti–CD24-FITC (clone M1/69) and 0.25 μg/ml anti–CD24-PE-Cy5 (Fig. 
S2, B and C)
To identify previously described (Stingl et al., 2006) MaCFCs, 
MYOs, and MRUs (stem cells) and locate them within the three-region 
CD24 profi le described both in this study and in a previous work (Sleeman 
et al., 2006), cells were stained with anti–CD24-PE (clone M1/69; 1.5 
μg/ml; BD Biosciences), anti–CD49f-FITC (clone GoH3; 1:50 vol/vol 
dilution; BD Biosciences), and 0.25 μg/ml anti–CD45-PE-Cy7 (clone 30-
F11; BD Biosciences) together with 0.25 μg/ml anti–CD24-PE-Cy5 (clone 
M1/69; Insight Biotechnology). 0.01% TO-PRO-3 was used to detect 
dead cells. Nonspecifi c IgG controls were used for compensation and 
to set sort gates. Analysis and exclusion of dead cells, CD45+ cells and 
nonsingle cells was performed as previously described (Sleeman et al., 
2006). MaCFC, MYO, and MRU cells were identifi ed, and their location 
within the three regions defi ned by anti–CD24-PE-Cy5 was determined by 
staining (Fig. S2 A).
Immunofl uorescence staining and in vitro analysis
For prominin-1 and ERα staining of frozen sections of mouse mammary 
gland, small pieces (5 mm3) of 10-wk-old mouse mammary fat pads were 
fi xed in 4% paraformaldehyde in PBS for 1 h, infi ltrated with 1 M sucrose 
overnight at 4°C as a cryoprotectant, and snap frozen in isopentane 
cooled in liquid nitrogen. 10-μm frozen sections were cut and stored at 
–80°C. Before use, sections were thawed at RT for 15–30 min and stained 
essentially as previously described (Smalley, et al., 1998) with 5 μg/ml 
anti–prominin-1 (rat monoclonal clone 13A4; Insight Biotechnology) and 
6 μg/ml anti-ERα (mouse monoclonal clone 1D5; Insight Biotechnology). 
Sections were counterstained with TO-PRO-3 (0.01% in PBS) and mounted 
in Vectashield H1000 mounting medium (Vector Laboratories). For cyto-
skeletal marker staining, tissue was snap frozen with no prior fi xation. 
Frozen sections were fi xed in 1:1 methanol acetone at –20°C for 5 min 
and stained with antibodies against 2.1 μg/ml CK14 (mouse IgG3 clone 
LL002; Lab Vision) and 2 μg/ml CK8/18 (CK18; mouse IgG1 clone 5D3; 
Vision Biosystems) in addition to DAPI. Secondary antibodies were isotype-
specifi c goat anti–mouse antibodies (A21127 and A21157; Invitrogen) 
conjugated to Alexa Fluor 488 or 555 fl uorochromes. Sections were 
mounted in Vectashield. Lack of nonspecifi c staining by secondary anti-
bodies was confi rmed using isotype-matched control primary antibodies 
(Cambridge Bioscience). Lack of cross-reactivity was confi rmed with controls 
incubated with single primary antibodies and both secondary antibodies.
Immunophenotyping of cell populations sorted onto slides was per-
formed as previously described (Sleeman et al., 2006) using the anti-CK14 
(LLOO2) and anti-CK18 (5D3) primary antibodies, secondary antibodies, 
and DAPI, as described in the previous paragraph. Samples were mounted 
in Vectashield. For immunostaining of clones on coverslips, mouse mam-
mary cells were cultured on coverslips with a feeder layer of irradiated 
3T3-L1 preadipocytes in 1:1 DME/F12 (Sigma-Aldrich) with 10% fetal calf 
serum (Invitrogen), 5 μg/ml insulin (Sigma-Aldrich), 10 ng/ml epidermal 
growth factor (Sigma-Aldrich), and 10 ng/ml cholera toxin (Sigma-
 Aldrich). Cultures were maintained at 37°C in a 5% vol/vol CO2/5% vol/
vol O2 atmosphere for 8–10 d before fi xation in cold (−20°C) 1:1 methanol/
acetone and staining (Smalley et al., 1998). Clones were stained with anti-
CK14 (LLOO2) and anti-CK18 (5D3) primary antibodies, secondary anti-
bodies, and DAPI, as described in the previous paragraph. Samples were 
mounted in Vectashield.
All fl uorescence samples were examined at room temperature using 
a microscope (TCS SP2; Leica) with an Acousto-Optical Beam Splitter and 
lasers exciting at 405, 488, 543, and 633 nm (Leica). PMT levels were set 
using control samples. Multicolor images were collected sequentially in 
three or four channels. Images of clones were taken using a 20×/0.70 NA 
dry HC Plan Apo CS lens (Leica). Images of sections and cells sorted on 
slides were taken using a 40×/1.25 NA oil HCX Plan Apo lens. Images 
were captured using the Leica system and Leica TCS image acquisition 
software. Overlays were generated using TCS software. Photo montages 
were generated using Photoshop (Adobe), but were not further processed.
Analysis of the in vitro colony-forming potential of mammary cell 
subpopulations was performed in a 96-well plate format, as previously de-
scribed (Smalley et al., 2005). The feeder layers, growth media, and condi-
tions were identical to those described in this section for coverslip culture.
Cell cycle analysis
Cells were pelleted and resuspended in ice-cold 70% ethanol and 
maintained at 4°C for at least 15 min. They were then pelleted and resus-
pended in PBS containing 40 μg/ml propidium iodide and 100 μg/ml 
RNase A. Samples were incubated at 37°C for 20 min and analyzed by 
standard protocols.
qPCR analysis
qPCR reactions were performed as previously described (Sleeman et al., 
2006) to determine fold changes in expression of a selection of genes 
(Table S1) in mammary epithelial cell subpopulations, compared with a 
 leukocyte-depleted, bulk mammary epithelial cell (CD45−/CD24+)  comparator 
sample. Signifi cant deviation of the mean value of the three data points 
from a fold difference of 1 (no change compared with the comparator 
sample) was tested using a t test on log10-transformed data.
Cleared mammary fat pad transplantation
Freshly isolated cells were sorted and transplanted (Sleeman et al., 2006). 
There was no intervening culture period before transplantation. All animal 
work was approved by the Local Ethics Committee and performed under 
Home Offi ce approval. 8 wk after transplantation, fat pads were whole-
mounted and analyzed, as previously described (Sleeman et al., 2006). 
Failed clears were excluded from the analysis. Wholemounts were exam-
ined on a binocular microscope (MZ12.5; Leica) with a Plan 1× lens and 
a Cold Light Source (Leica). Images were captured with a camera (DFC500; 
Leica) and IM50 image acquisition software (with auto white balance 
and auto exposure activated). A proportion of successful transplants had a 
region of epithelial outgrowth dissected out under the microscope for 
 paraffi n embedding by routine methods and routine immunocytochemistry 
to detect SMA (clone 1A4; Sigma-Aldrich) and ERα (clone 1D5). Images of 
stained sections were captured on a microscope (DM RA2; Leica) using a 
63× oil Plan Apo lens (N/A 1.32), a camera (DFC320; Leica), and IM50 
image acquisition software (with auto white balance and auto exposure 
activated). Photo montages were generated using Photoshop, but were not 
further processed.
To confi rm that differential survival of cells before transplantation did 
not confound assessment of their relative engraftment potentials, viability 
assays of CD24Low, CD24High/prominin-1−, and CD24High/prominin-1+ 
cells were performed by TO-PRO-3 staining and fl ow cytometric analysis 
immediately after separation, and again after 3.5 h on ice. The analysis 
showed that CD24Low cells, which were the most potent at repopulating 
cleared fat pads (Fig. 5), had a viability immediately after sorting of 
>70%, dropping to >65% after 3.5 h. CD24High/prominin-1− cells had 
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a viability of >90% immediately after sorting, and this was maintained 
 after 3.5 h on ice. CD24High/prominin-1+ cells had a viability of >75% im-
mediately after sorting, and this was also maintained at >75% after 3.5 h 
on ice. Therefore, differential sensitivity to the sorting procedure or to being 
maintained on ice during transplantation could not explain the differences 
in engraftment potential.
Online supplemental material
Table S1 lists the genes examined by qPCR analysis. Fig. S1 shows 
the characterization of mouse mammary epithelial cell subpopulations. 
Fig. S2 shows the identifi cation of MaCFC, Myo, and MRU regions. 
Online supplemental material is available at http://www.jcb.org/cgi/
content/full/jcb.200604065/DC1.
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